Glycosaminoglycans for treatment emotional dysfunctions

Details Glycosaminoglycans for treatment emotional dysfunctions Glycosaminoglycans for treatment emotional dysfunctions

A - Human Necessities

61

K

A61K 31/715 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2526201

The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (.forall.200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.

L'invention concerne l'utilisation de fractions de glycosaminoglycanes de poids moléculaire moyen de 2400 (?200) D destinées à la préparation de compositions pharmaceutiques appropriées au traitement de troubles émotionnels, en particulier les troubles dépressifs, les troubles anxieux, les névroses d'angoisse, l'agitation, la confusion.

Affiliated with

Also associated with

Rating

Glycosaminoglycans for treatment emotional dysfunctions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycosaminoglycans for treatment emotional dysfunctions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosaminoglycans for treatment emotional dysfunctions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2046640